Use of methylnaltrexone to treat immune suppression

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/44 (2006.01) A61K 31/00 (2006.01) A61K 31/485 (2006.01)

Patent

CA 2449175

Methods for treating opioid-induced immune suppression with peripheral opioid antagonists are provided. In one embodiment, the method involves administering methylnaltrexone. Pharmaceutical compositions comprising an opioid, an opioid antagonist, and a pharmaceutical agent are also provided.

L'invention se rapporte à des procédés de traitement de l'immunodépression provoquée par des opioïdes au moyen d'antagonistes des opioïdes périphériques. Selon un mode de réalisation, le procédé consiste à administrer de la méthylnaltrexone. L'invention a également trait à des compositions pharmaceutiques comprenant un opioïde, un antagoniste des opioïdes et un agent pharmaceutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of methylnaltrexone to treat immune suppression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of methylnaltrexone to treat immune suppression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of methylnaltrexone to treat immune suppression will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1939827

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.